Join
Live feed
·
NEWSReleasevia Quantisnow
European Biotech Acquisition Corp. logo

Oculis SA And European Biotech Acquisition Corp Announce Business Combination Agreement To Create Nasdaq-lListed BioPharmaceutical Company Driving Breakthrough Innovations In Ophthalmology

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EBAC (European Biotech Acquisition Corp.) and more on Quantisnow.